Bond.az White LogoBond.az Black Logo

#negative

Latest news and interesting information about negative.

Today / 12:52
|
761

ElvalHalcor Q1 2026 shows strong growth

ElvalHalcor Q1 2026 results: revenue EUR 1 billion, EBITDA up 33%, stock dips slightly.

0
Today / 12:42
|
965

Philly Fed Manufacturing Index Falls Negative

Philly Fed Manufacturing Index drops to -0.4, missing forecasts. Explore the implications for the economy and markets.

0
Today / 12:01
|
628

Navios Maritime Unit earnings beat estimates by $1.25

Navios Maritime Unit beats Q1 earnings estimates with EPS of $3.35 vs $2.10 estimate, revenue of $357M vs $308.33M estimate.

0
Today / 11:23
|
977

Quantum Cyber Files Patent for GPS-Independent Drone System

Quantum Cyber files patent for GPS-independent drone system utilizing quantum sensor navigation and swarm defense. Stock surged 230%.

0
Today / 11:10
|
743

ADS earnings beat forecasts by $0.12

ADS reported Q4 EPS of $1.07, beating estimates by $0.12. Revenue also topped forecasts at $676.8M.

0
Today / 10:24
|
364

Immix Biopharma reports 95% complete response rate in trial

Immix Biopharma's NEXICART-2 trial achieves 95% complete response rate in AL Amyloidosis patients. Promising results for CAR-T therapy NXC-201.

0
Today / 08:14
|
515

Jefferies downgrades ZoomInfo stock on AI

Jefferies downgrades ZoomInfo to Hold, cuts price target to $4.00 on weak demand and AI adoption headwinds.

0
Today / 07:31
|
952

TD Cowen Reaffirms Nvidia Buy on AI Demand

TD Cowen reaffirms Nvidia Buy rating with $275 target on strong AI demand. Stock undervalued with PEG 0.67. Analyst highlights positives and negatives.

0
Today / 02:32
|
204

Golar earnings beat estimates by $0.19

Golar beats Q1 earnings and revenue estimates. Stock up 48% in the past year.

0
Today / 01:40
|
692

Immunovant director sells $192,000 in shares

Immunovant director Atul Pande sold $192,000 worth of shares. Stock up 147% in past year, but company remains unprofitable.

0
Yesterday / 20:42
|
664

Vivos revenue jumps 70% in Q1

Vivos Therapeutics Q1 2026 revenue up 70% to $5.1M. Stock near 52-week low at $0.59. Cash concerns remain.

0
Yesterday / 14:30
|
804

Fermi America Q1 2026: $189M Loss Reported

Fermi America Q1 2026 reports $189M loss, revenue miss, and stock rise. Details on Project Matador and financials.

0
Yesterday / 12:20
|
658

EuroDry earnings miss estimates

EuroDry first-quarter earnings miss estimates. EPS of $0.12, revenue of $12.8 million.

0
Yesterday / 11:30
|
911

Keefe Bruyette Reiterates Bitdeer Rating on AI Shift

Keefe, Bruyette & Woods reiterates Market Perform rating on Bitdeer stock with $11.50 target amid AI mix shift and Tydal project focus.

0
Yesterday / 10:20
|
753

VF earnings beat estimates, revenue up

VF reports Q4 earnings beat with EPS of $0.06, revenue of $2.17B exceeds expectations.

0
Yesterday / 07:04
|
360

Molina Healthcare Stock: Under Margin Pressure

Molina Healthcare stock faces margin pressures from rising medical loss ratio and membership attrition. Analysts downgrade outlook; potential off-cycle rate adjustments offer upside.

0
Yesterday / 06:16
|
922

UN: Construction companies ignore climate

UN official Elizabeth Maruma Mrema says some construction companies ignore climate conditions, focusing solely on profit.

0
Yesterday / 05:20
|
870

AI is coming, young people are booing

AI is coming, but young people are booing: news about AI impact, job cuts, and Gen Z's reaction.

0
Yesterday / 04:33
|
804

Franklin Wireless earnings miss by $0.12

Franklin Wireless Q4 earnings miss estimates: EPS -$0.130 vs -$0.010 expected, revenue $3.44M vs $9.9M.

0
Yesterday / 04:32
|
903

Prabowo sets 2027 fiscal deficit target at 1.8-2.4%

Indonesia's President Prabowo sets 2027 fiscal deficit target of 1.8-2.4% of GDP, aims for 6.5% economic growth.

0
Yesterday / 04:14
|
619

PowerBank Q3 2026 Stock Up Despite Loss

PowerBank Q3 2026 results: net loss but stock rises. Growth driven by solar and battery projects despite challenges.

0
Yesterday / 03:53
|
815

Australia tax reform reshapes investment landscape

Australia's tax reform redirects investors to high-dividend stocks. Capital gains tax increases shift focus from growth to income.

0
Yesterday / 03:33
|
840

Iovance Biotherapeutics: stock gains on melanoma data

Iovance Biotherapeutics stock gains momentum on real-world melanoma data for Amtagvi. Despite losses, analysts see upside from manufacturing efficiencies and label expansion.

0
Yesterday / 02:32
|
420

ZTO Express Cayman earnings beat, revenue tops estimates

ZTO Express Cayman first-quarter earnings miss estimates but revenue beats. Stock down 6.88% in 3 months, up 38.29% in 12 months.

0
2026-05-19 22:15
|
586

Warning for noise-making drivers | Bond.az

Traffic police warn drivers about illegal muffler modifications causing noise at night. Fines up to 500 manat for exceeding 96 decibels.

0
2026-05-19 19:51
|
929

SandRidge Energy Stock Rating Upgraded to Hold

Freedom Broker upgraded SandRidge Energy to Hold after strong Q1 2026 results. Dividend increased by 8.3% to $0.13 per share.

0
2026-05-19 11:50
|
451

CytoSorbents Q1 2026 Misses Forecasts, Stock Falls

CytoSorbents Q1 2026 results: EPS of -$0.05 misses estimate, revenue of $8.9M falls short, stock drops 7.53%. Company cuts costs and targets breakeven in H2 2026.

0
2026-05-19 11:34
|
389

Hongkong Land Recycles $600M Capital in Q1

Hongkong Land recycles $600 million capital in Q1 2026, reaching 90% of $4B target. Buys back shares, launches Singapore fund.

0
2026-05-19 11:01
|
500

Canaan Earnings Miss Estimates by $0.83

Canaan first quarter results: EPS -$0.860, revenue $62.7M, missing estimates.

0
2026-05-19 10:34
|
929

Bilibili earnings beat estimates by ¥0.25

Bilibili Q1 earnings beat estimates by ¥0.25 but revenue slightly missed. Stock down 36% in 3 months.

0
...